Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Webinars
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • AI and healthcare
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • AI and healthcare
    • Industry Perspective
  • Home
  • News
  • Industry
  • Pharma News
  • CDSCO (Central Drugs...

CDSCO (Central Drugs Standard Control Organisation) News - Page 7

Zydus Amplitude receives CE mark for robotic surgical system Andy

Zydus Lifesciences Secures CDSCO Panel Approval for Usnoflast Capsule Interaction Study

Parthika Patel5 Oct 2025 9:30 AM IST
New Delhi: The Subject Expert Committee (SEC) on Investigational New Drugs under CDSCO has recommended approval for Zydus Lifesciences Limited to...
CDSCO Flags MSD Pharmas Cancer Drug Trial Over Indian Representation, Control Arm

CDSCO Flags MSD Pharma's Cancer Drug Trial Over Indian Representation, Control Arm

Parthika Patel4 Oct 2025 4:11 PM IST
New Delhi: The Subject Expert Committee (SEC) on Oncology under the Central Drugs Standard Control Organization (CDSCO) has raised critical concerns...
MSD Pharma gets CDSCO panel nod for New Indications of Pembrolizumab in India

MSD Pharma gets CDSCO panel nod for New Indications of Pembrolizumab in India

Susmita Roy3 Oct 2025 8:36 PM IST
New Delhi: The Subject Expert Committee functioning under the Central Drugs Standard Control Organization (CDSCO) has granted approval for additional...
CDSCO Panel Directs Malik Lifesciences to Revise Phase III Trial Protocol for Tamsulosin, Dutasteride, Tadalafil FDC

CDSCO Panel Directs Malik Lifesciences to Revise Phase III Trial Protocol for Tamsulosin, Dutasteride, Tadalafil FDC

Parthika Patel3 Oct 2025 7:17 PM IST
New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has directed Malik Lifesciences Pvt Ltd to...
MSN Labs Secures SEC Nod for Phase III Trial of Vibegron 75 mg, Excluding Refractory OAB Patients

MSN Lab gets CDSCO panel nod for Phase IV CT of Tofacitinib Tablets 10 mg

Susmita Roy2 Oct 2025 12:15 PM IST
New Delhi: The Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to MSN...
MSN Labs Secures SEC Nod for Phase III Trial of Vibegron 75 mg, Excluding Refractory OAB Patients

SEC Recommends Phase III Trial of MSN Labs' Vibegron Against Mirabegron in Overactive Bladder

Parthika Patel2 Oct 2025 10:30 AM IST
New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) has recommended granting permission to MSN...
Khadgawan CHC Honoured with ISO Certification for Vaccine Storage Standards

Not All Combipacks Are New Drugs: CDSCO Defines Approval Rules for Lyophilized Injections

Susmita Roy1 Oct 2025 4:50 PM IST
New Delhi: The Central Drugs Standard Control Organization (CDSCO) has issued a notice clarifying the regulatory pathway for approval of combipack...
Bombay High Court Blocks Use of Deceptively Similar Diabetes Drug Trademark

Bombay HC Quashes Maharashtra FDA, CDSCO Stop-Production Orders Against 2 Pharma Firms

Susmita Roy30 Sept 2025 4:08 PM IST
Mumbai: The Bombay High Court has struck down orders issued by the Maharashtra Food and Drug Administration (FDA) and the Central Drugs Standard...
Intas Pharma Told to Narrow Margins, Extend Duration in Pembrolizumab Trial Protocol

Intas Pharma Told to Narrow Margins, Extend Duration in Pembrolizumab Trial Protocol

Farhat Nasim30 Sept 2025 3:09 PM IST
New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has directed Intas Pharmaceuticals Ltd. to...
MSN Labs Secures SEC Nod for Phase III Trial of Vibegron 75 mg, Excluding Refractory OAB Patients

MSN Lab gets CDSCO panel nod for Phase IV CT of Tofacitinib Oral Solution

Susmita Roy29 Sept 2025 9:56 PM IST
New Delhi: The Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO) has granted approval to MSN...
Heparin Injection, Vitamin D Tablets Fail Quality Test, 2 Drugmakers Blacklisted by CGMSC

Health Ministry Bans 34 Key Antibiotics, Antivirals for Animal Use, See List

Susmita Roy29 Sept 2025 9:51 PM IST
New Delhi: Through a recent Gazette notification, the Ministry of Health and Family Welfare has notified a ban on the import, manufacture, sale, and...
CDSCO Panel Recommends Updating Prescribing Information for Sanofis Vaccine

CDSCO Panel Recommends Updating Prescribing Information for Sanofi's Vaccine

Susmita Roy28 Sept 2025 1:15 PM IST
New Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended updation of the...
PrevNext

Editorial

Effect of Micronized Purified Flavonoid Fraction (MPFF) in Indian patients with Grade I-II Hemorrhoids: the IMPACT HD Study

Effect of Micronized Purified Flavonoid Fraction (MPFF) in Indian patients with Grade I-II...

Gliclazide - Revisiting a Preferred Sulphonylurea in 2025 - Dr Silima Tarenia and Dr Shehzad Ruman

Gliclazide - Revisiting a Preferred Sulphonylurea in 2025 - Dr Silima Tarenia and Dr Shehzad Ruman

Aspirin in Obese T2D with Atherogenic Dyslipidemia: Identifying the Ideal Candidates

Aspirin in Obese T2D with Atherogenic Dyslipidemia: Identifying the Ideal Candidates

Explainer video: Advise- Educating Patients about Addressing Glycemic and Weight Goals

Explainer video: Advise- Educating Patients about Addressing Glycemic and Weight Goals

Risk Beyond Control: Inherited and Causal CV Risk Factors and the Role of Aspirin

Risk Beyond Control: Inherited and Causal CV Risk Factors and the Role of Aspirin

View All

Journal Club Today

Worlds oldest blood pressure drug may be effective against aggressive brain tumour: Study suggests

World's oldest blood pressure drug may be effective against aggressive brain tumour: Study suggests

View All

Health News Today

Health Bulletin 19/November/2025

Health Bulletin 19/November/2025

View All
© 2022 All Rights Reserved.
Powered By: Hocalwire
X
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok